Dr. Raj Arora's Ozempic side effects breakdown, fact-checked

What did @drrajarora actually say?

Honestly? Almost nothing. The transcript of this 756,000-view video consists entirely of song lyrics or audio recognition: "That's the song I know. That's the song I know. That's the song I know." There is no spoken medical content in this transcript to evaluate. The caption promises a breakdown of common Ozempic side effects, but whatever clinical information may exist in the video was not captured in the provided transcript.

This happens sometimes on TikTok. A creator uses a trending audio clip as an intro, or the transcription software picks up background music instead of speech. The result is a fact-checker's nightmare: a video with nearly a million views, a medical hashtag, and a verified doctor handle, producing zero evaluable claims.

Does the science back this up?

There is no claim here to test against the science. But since the caption specifically references Ozempic side effects, and since 756,000 people watched this, it is worth covering what the actual evidence says, regardless of what was or was not said on screen.

Semaglutide's side effect profile is well-documented. The SUSTAIN and STEP trial series, published across multiple journals between 2016 and 2021, consistently found that gastrointestinal effects dominated: nausea affected roughly 20 percent of participants, vomiting around 9 percent, and diarrhea approximately 9 percent (Marso et al., 2016, NEJM; Wilding et al., 2021, NEJM). These are dose-dependent and typically peak during dose escalation. More serious but rarer concerns include pancreatitis risk, thyroid C-cell tumor signals from rodent studies (clinical relevance in humans remains unresolved), and gastroparesis cases flagged in post-marketing surveillance. The FDA updated Ozempic's label in 2023 to include gastroparesis as a reported adverse event.

What did they get wrong (or right)?

There is simply nothing to evaluate from this transcript. The creator cannot be credited or criticized for medical accuracy when the available transcript contains no medical content whatsoever.

What is worth flagging is a structural problem with this kind of video. A physician account, using the hashtag "doctorsoftiktok," signals authority to viewers who may be making real decisions about starting or stopping a GLP-1 medication. If the actual video content was incomplete, unclear, or relied heavily on text overlays that did not get transcribed, that is a gap worth noting. Viewers who only catch the audio, or who watch without reading on-screen text, may come away with an incomplete picture of a drug that carries real clinical considerations.

The side effects of semaglutide are not trivial. Gastroparesis, in particular, has generated significant patient concern and legal activity. Any educational video on this topic carries a responsibility to be complete.

What should you actually know?

If you found this video while researching Ozempic side effects, here is what the clinical literature actually supports. Nausea is the most common complaint and affects roughly one in five users, particularly during the first weeks of treatment. It usually improves but does not always resolve. Gastrointestinal symptoms are the leading reason people discontinue GLP-1 therapy in trials.

Beyond the GI profile, there are legitimate open questions. The thyroid tumor signal observed in rodent studies has not been confirmed in humans, but semaglutide remains contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2. Acute pancreatitis has been reported, though causality is debated. Muscle loss during rapid weight reduction is a real concern that several researchers, including Bikou et al. (2023, Obesity Reviews), have argued deserves more attention in prescribing conversations.

If you are currently on a GLP-1 medication and experiencing side effects, contact your prescriber. Do not adjust your dose based on social media content, including content from physician accounts.